Solitary Plasmacytoma in the Setting of Langerhans Cell Histiocytosis

References

• Komp, D.M. (1987) "Historical perspectives of LCH", Hematol.—Oncol. Clin. N. Am. 1(1).
   Google Scholar
• Lichtenstein, L. (1953) "Histiocytosis X: integration of eosinophilic granuloma of bone, 'Letterer—Siwe disease' and 'Schuller—Christian disease' as related manifestations of a single nosologic entity", AMA Arch. Pathol. 56, 84–102.
   PubMedGoogle Scholar
• Osband, M.F. (1987) "Histiocytosis X, Langerhans cell histiocytosis", Hematol.—Oncol. Clin. N. Am. 1, 737–751.
   PubMedGoogle Scholar
• The Histiocyte Society(1987) "Histiocytosis syndromes in childhood", Lancet 1, 208–209.
   PubMed Web of Science ®Google Scholar
• Langerhans, P. (1868) "Ueber die Nerven der menschlichen Haut", Virchows Arch. IPathol. Anat.] 44, 325–337.
   Google Scholar
• Wolff, K. (1972) "The Langerhans cell", Curr. Probl. Dermatol. 4, 79–145.
   PubMedGoogle Scholar
• Mierau, G.W., Wills, E.J. and Steele, P.O. (1994) "Ultrastru-ctural studies in Langerhans cell histiocytosis: a search for viral etiology", Pediatr. Pathol. 14, 895–904.
   PubMed Web of Science ®Google Scholar
• Kannourakis, G. and Abbas, A. (1994) "The role of cytokines in the pathogenesis of Langerhans cell histiocytosis", Br. J. Cancer 70, S37—S40.
   Web of Science ®Google Scholar
• Ruco, L.P., Stoppacciaro, A., Vitolo, D., et al. (1993) "Expression of adhesion molecules in Langerhans cell histiocytosis", Histopathology 23, 29–37.
   PubMed Web of Science ®Google Scholar
• De Graaf, J.H., Tamminga, R.Y.J., Kamps, WA., et al. (1994) "Langerhans cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation", Am. J. Pathol. 144, 466–472.
   PubMed Web of Science ®Google Scholar
• De Graaf, J.H., Tamminga, R.Y.J., Kamps, W.A., et al. (1995) "Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells", Am. J. Pathol. 147, 1161–1171.
   PubMed Web of Science ®Google Scholar
• Katz, A.M., Rosenthal, D., Jakubovic, H.R., et al. (1991) "Langerhans cell histiocytosis in monozygotic twins", J. Am. Acad. Dermatol. 24, 32–37.
   PubMed Web of Science ®Google Scholar
• William, CL., Busque, L., Griffith, B.B., et al. (1994) "Langerhans cell histiocytosis (Histiocytosis X)—a clonal proliferative disease", N. Engl. J. Med. 331, 154–160.
   PubMed Web of Science ®Google Scholar
• Jaffe, R. (1987) "Pathology of histiocytosis X", Perspect. Pediatr. Pathol. 9, 4.
   PubMedGoogle Scholar
• Birbeck, M.S., Breathnach, A.S. and Everall, J.D. (1961) "An electron microscopic study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo", J. Investig. Dermatol. 31, 51–64.
   Web of Science ®Google Scholar
• Van Heerde, P. and Egeler, R.M. (1991) "The cytology of Langerhans cell histiocytosis (Histiocytosis X)", Cytopathology 2, 149–158.
   PubMed Web of Science ®Google Scholar
• Mierau, G.W. and Favara, B.E. (1986) "S100 protein immunohistochemistry and electron microscopy in the diagnosis of Langerhans cell proliferative disorders: a comparative assessment", Ultrastruct. Pathol. 10, 303.
   PubMed Web of Science ®Google Scholar
• Lieberman, PH., Jones, CR., Steinman, R.M., et al. (1996) "Langerhans cell (Eosinophilic) granulomatosis. A dinico-pathologic study encompassing 50 years", Am. J. Surg. Pathol. 20(5), 519–552.
   PubMed Web of Science ®Google Scholar
• Giona, F., Caruso, R., Testi, A., et al. (1997) "Langerhans cell histiocytosis in adults. A clinical and therapeutic analysis of 11 patients from a single institution", Cancer 80(9), 1786–1791.
   PubMed Web of Science ®Google Scholar
• Womer, R.B., Anunciato, K.R. and Chehrenamaq, M. (1995) "Oral methotrexate and alternate day prednisone for low risk Langerhans cell histiocytosis", Med. Pediatr. Oncol. 25(2), 70–73.
   PubMedGoogle Scholar
• Lambardi, A., El Hachem, M.C., Rana, I., et al. (1997) "2'Deoxycoformycin as treatment in refractory Langerhans cell histiocytosis", J. Pediatr. 130(2), 330.
   Web of Science ®Google Scholar
• Viana, M.B., Oliveira, B.M., Silva, C.M., et al. (1991) "Etopo-side in the treatment of six children with Langerhans cell histiocytosis", Med. Pediatr. Oncol. 19(4), 289–294.
   PubMedGoogle Scholar
• Arico, M., Collella, R., Counter, V, et al. (1995) "Cyclosporine therapy for refractory Langerhans cell histiocytosis", Med. Pediatr. Oncol. 25, 12–16.
   PubMedGoogle Scholar
• Carrera, C.J., Terai, C., Lotz, M., et al. (1990) "Potent toxicity of 2-chlorodeoxyadenosine towards human monocytes in vitro and in vivo: a novel approach to immunosuppressive therapy", J. Clin. Investig. 86, 1480–1488.
   PubMed Web of Science ®Google Scholar
• Saven, A., Figueroa, ML., Piro, L.D., et al. (1993) "2-Chlorodeoxyadenosine to treat refractory histiocytosis X (Letter)", N. Engl. J. Med. 329, 734–735.
   PubMed Web of Science ®Google Scholar
• Stine, K.C., Saylors, R.L., Williams, L.L., et al. (1997) "2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis in pediatric patients", Med. Pediatr. Oncol. 29(4), 288–292.
   PubMedGoogle Scholar
• Ringden, O., Ashstorm, L., Lonnqvist, B., et al. (1987) "Allogenic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis", N. Engl. J. Med. 316, 733–735.
   PubMed Web of Science ®Google Scholar
• Greinix, H.T., Storb, R., Sanders, J.E., et al. (1992) "Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis", Bone Marrow Transplant. 10, 39–44.
   PubMed Web of Science ®Google Scholar
• Conter, V, Reciputo, A., Arrigo, C., et al. (1996) "Bone marrow transplant for refractory Langerhans cell histiocytosis", Haematologica 81(5), 468–471.
   PubMed Web of Science ®Google Scholar
• Ringden, O., Lonqvist, B. and Ho1st, M. (1997) "12-Year follow-up of allogenic bone-marrow transplant for Langerhans cell histiocytosis", Lancet 349, 476.
   PubMed Web of Science ®Google Scholar
• Kelly, K.M. and Pritchard, J. (1994) "Monoclonal antibody therapy in Langerhans cell histiocytosis-feasible and reaso-nable?", Br. J. Cancer 70, 554—S55.
   Web of Science ®Google Scholar
• Gaffney, C.C., Dawes, P.J.D.K. and Jackson, D. (1987) "Plasmacytoma of the head and neck", Clin. Radiol. 38, 385–388.
   PubMed Web of Science ®Google Scholar
• Galieni, R, Cavo, M., Avvisati, G., et al. (1995) "Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities?", Ann. Oncol. 6(7), 687–691.
   PubMed Web of Science ®Google Scholar
• Wax, M.K., Yun, K.J. and Omar, R.A. (1993) "Extramedullary plasmacytomas of the head and neck", Otolaryngol. Head Neck Surg. 109(5), 877–885.
   PubMed Web of Science ®Google Scholar
• Samuel, L., Candlish, W. and Stark, A. (1997) "Solitary extramedullary plasmacytoma (Letter)", N. Engl. J. Med. 337(16), 1174.
   PubMed Web of Science ®Google Scholar
• Chang, MY, Shin, L.Y., Dunn R, et al. (1994) "Solitary plasmacytoma of bone", J. Formos. Med. Assoc. 93(5), 397–402.
   PubMedGoogle Scholar
• Aviles, A., Huerta-Guzman, J., Delgado, S., et al. (1996) "Improved outcome in solitary bone plasmacytomata with combined therapy", Hematol. Oncol. 14(3), 111–117.
   PubMed Web of Science ®Google Scholar
• Egeler, R.M., Neglia, J.P., Puccetti, D.M., et al. (1993) "Association of Langerhans cell histiocytosis with malignant neoplasms", Cancer 71(3), 865–873.
   PubMed Web of Science ®Google Scholar
• Yamashita, H., Nagayama, M., Kawashima, M., et al. (1992) "Langerhans-cell histiocytosis in an adult patient with multiple myeloma", Gin. Exp. Dermatol. 17(4), 275–278.
   Web of Science ®Google Scholar
• Roger, D.J., Bono, J.V. and Singh, J.K. (1992) "Plasmacytoma arising from a focus of chronic osteomyelitis", J. Bone Jt. Surg. 74-A(4), 619–623.
   Google Scholar
• Schwartz, R.E. and Burt, M. (1996) "Radiation-associated malignant tumors of the chest wall", Ann. Surg. Oncol. 3(4), 387–392.
   PubMed Web of Science ®Google Scholar
• Foss, H.D., Herbst, H., Araujo, I., Hummel, M., Berb, E., Schmitt-Graff, A. and Stein, H. (1997) "Monokine expression in Langerhans cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai—Dorfman disease)", J. Pathol. 179(1), 60–65.
   Web of Science ®Google Scholar
• Le, J., Reis, L.F. and Vilcek, J. (1988) "Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line", Lymphokine Res. 7(2), 99–106.
   PubMedGoogle Scholar
• Van Damme, J., Opdenakker, G., Simpson, R.J., Rubira, Cayphas, S., Vink, A., Billiau, A. and Van Snick, J. (1987) "Identification of human 26-kD protein, interferon beta 2 (]FN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor", J. Exp. Med. 165(3), 914–919.
   PubMed Web of Science ®Google Scholar
• Lust, J.A. and Donovan, K.A. (1999) "The role of interleukin-1 beta in the pathogenesis of multiple myeloma. [Review]", Hematol.—Oncol. Clin. N. Am. 13(6), 1117–1125.
   PubMed Web of Science ®Google Scholar
• Mitchel, RE., Jackson, J.S., McCann, R.A. and Boreham, D.R. (1999) "The adaptive response modifies latency for radiation-induced myeloid leukemia in CBA/H mice", Radiat. Res. 152(3), 273–279.
   PubMed Web of Science ®Google Scholar
• Epstein, J., Xiao, H. and Xiao-Yan, He (1990) "Markers of multiple hematopoietic cell lineages in multiple myeloma", N. Engl. J. Med. 322(10), 664–668.
   PubMed Web of Science ®Google Scholar